2015 Apr 16
Immunotherapy research in pancreatic cancer given $1m boost
Douglas Fearon has received a grant to support his research into eliminating T cell barriers in pancreatic cancer patients. Read more
2015 Apr 15
New genomic research amends earlier triple negative breast cancer finding
A paper in Nature from Mark Rubin, Sandra Shin and Juan Miguel Mosquera underscores the importance of independent study validation and careful assay development. Read more
2015 Apr 15
Big Data Key to Precision Medicine's Success
Mark A. Rubin, director of the Institute for Precision Medicine, writes in Nature about the practicalities of realizing the potential of precision medicine. Read more
2015 Apr 14
Researchers Sequence Genome of Anaplastic Large Cell Lymphoma
A team of researchers led by Giorgio Inghirami has discovered a pair of genetic mutations that drive tumor growth in patients who have a deadly subtype of T-cell lymphoma. Read more
2015 Apr 13
Researcher's resolve leads to breakthrough drug
Selina Chen-Kiang's investigations into the cell cycle helped lead to the successful launch of CDK4/6 inhibitor palbociclib (IBRANCE). Read more
2015 Apr 12
Can cancer be stopped?
Harold Varmus, M.D., pens a guest piece in the New York Daily News about the remarkable progress made in cancer research and the daunting road ahead. Read more
2015 Apr 09
Dattatreyudu Nori awarded one of India's highest civil honors
Dattatreyudu Nori, M.D., professor of clinical radiation oncology, has been awarded the Padma Shri, one of India's highest civil awards. Read more
2015 Apr 06
Minimally invasive surgery safe for rectal cancer
Heather Yeo, assistant professor of surgery, comments on a study about laparoscopic surgery options for rectal cancer. Read more
2015 Apr 02
Fish oil may reduce chemotherapy’s effectiveness
Dr. David Nanus comments on a report about the effects of fish oil on chemotherapy treatment. Read more
2015 Apr 01
Strategies for an Era of Tighter Research Budgets
Harold Varmus speaks to the Chronicle of Higher Education about budgetary challenges in academic research. Read more
2015 Apr 01
Weill research to be showcased at AACR 2015
More than 70 bench scientists, oncologists and computational biologists from Weill Cornell Medical College will present their work at AACR's annual meeting this month. Read more
2015 Apr 01
Fine-Combing the Cancer Transcriptome
Christopher Mason discusses cancer transcriptome analysis and the emerging area of “epitranscriptome” research. Read more
2015 Mar 27
Dr. Lewis Cantley Honored With the 2015 AACR Princess Takamatsu Memorial Lectureship
The American Association for Cancer Research (AACR) will honor Meyer director Lewis C. Cantley with the ninth annual Princess Takamatsu Memorial Lectureship at its annual meeting. Read more
2015 Mar 25
Lewis Cantley wins prestigious international award
Meyer Cancer Center director Lewis Cantley will receive the 2015 Canada Gairdner International Award Read more
2015 Mar 25
Private donors step up to save medical research
Dean Laurie H. Glimcher, M.D., penned a guest piece for the Washington Post about the lasting impact of sharp cuts to federal funding for medical research. Read more
2015 Mar 24
Surgeon receives National Physician of the Year Award
Dr. Fabrizio Michelassi has been awarded the Castle Connolly 2015 National Physician of the Year Award for Clinical Excellence Read more
2015 Mar 23
Immunotherapy in genitourinary cancers
Mark A. Rubin, M.D., director of Weill Cornell's Institute for Precision Medicine, talks to Targeted Oncology about immunotherapy in the field of genitourinary cancers. Read more
2015 Mar 19
Cancer prevention grant provides boost for blood test research
Andrew Dannenberg, M.D, has received $250,000 to fund research into creating a blood test to detect fatty tissue inflammation in the breast. Read more
2015 Mar 16
Agents Targeted Against PSMA for Prostate Cancer
Scott T. Tagawa, M.D., speaks to Targeted Oncology about PSMA-targeting agents for the treatment of prostate cancer. Read more
2015 Mar 10
Inhibiting the PI3K Pathway
Meyer Cancer Center director Lewis Cantley speaks to Cancer Therapy Advisor about progress in developing and testing effective PI3K pathway inhibitors. Read more
